Tune in as we explore the innovative world of DefenAge with Dr. Angela Bowers and Marda Levy, VP of Business Development at DefenAge. Dr. Bowers, a seasoned dermatologist, shares her first encounter with DefenAge in 2016 and her immediate impression of its unique ability to stimulate stem cells topically for youthful skin. Since integrating DefenAge into her practice, she has received significant positive feedback from her patients.

Marda Levy explains how DefenAge leverages regenerative medicine through defensins, molecules released by the immune system during wound healing. DefenAge’s efficacy is supported by robust clinical evidence, including a 2018 multicenter placebo-controlled study published in the Journal of Drugs in Dermatology. With over 30 clinical studies, DefenAge remains committed to scientific validation.

The discussion also covers the importance of the skin barrier, compared to a wall of bricks that can be disrupted by various factors. DefenAge products support the skin barrier, making them suitable for all skin types, including sensitive and rosacea-prone skin.

We conclude with a nod to the growing acceptance of skincare among men and DefenAge’s inclusive approach, catering to various skin types and concerns. DefenAge’s innovative use of defensins and commitment to scientific validation make it a leader in the skincare industry. Listen to the full episode now to learn more!

Explore DefenAge Products HERE

Hosted on Acast. See acast.com/privacy for more information.